UFP Technologies stock (US9026731015): medical packaging specialist in focus after recent earnings
UFP Technologies reported strong quarterly results driven by demand in medical device and life sciences packaging. The company focuses on customized, high-value packaging solutions for healthcare, operating as a critical partner to OEMs. Its business model benefits from high barriers to entry and long-term customer relationships in the specialized medical technology sector.
Trade Alert: Lead Independent Director Of UFP Technologies Daniel Croteau Has Sold Stock
UFP Technologies' Lead Independent Director, Daniel Croteau, recently sold US$635k worth of company shares, reducing his holding by 77%. While the sale occurred at current market prices, raising some caution, there have been no insider buys in the last year. Despite the limited insider ownership of 3.8%, the company is profitable and growing, leading to a cautious outlook from the analysis.
Trade Alert: Lead Independent Director Of UFP Technologies Daniel Croteau Has Sold Stock
UFP Technologies' Lead Independent Director, Daniel Croteau, recently sold US$635k worth of company stock, representing 77% of his entire holding. While the sale occurred around the current share price, it raises a degree of caution among observers as there have been no insider buys in the last year, although the company is profitable and growing. The article suggests that while insider selling is not ideal, the sale at current prices is less concerning than if it were at a lower valuation.
UFP Technologies stock (US9026731015): Shares fall after fresh trading weakness
UFP Technologies shares experienced a 3.16% drop in regular trading on May 15, 2026, with further weakness in after-hours trading, drawing investor attention. The company specializes in manufacturing components, devices, and packaging for healthcare and industrial markets. This price movement puts the stock on watch lists, though it is not attributed to a new corporate announcement but rather to market sentiment.
(UFPT) and the Role of Price-Sensitive Allocations
This article provides an advanced AI-driven analysis for Ufp Technologies Inc. (UFPT), indicating conflicting sentiment across different trading horizons and suggesting choppy conditions. It highlights an exceptional risk-reward setup targeting a 15.8% gain versus 0.3% risk. The analysis includes detailed institutional trading strategies (Long, Momentum Breakout, and Risk Hedging) and multi-timeframe signal analysis with support and resistance levels.
UFP Technologies stock (US9026731015): Director Croteau sells $635K in shares
UFP Technologies director Daniel Croteau sold 2,864 shares of the company's common stock at $221.71 per share, totaling approximately $635,000. This open-market transaction, filed with the SEC on May 14, 2026, reduced his direct holdings to 855 shares. The sale is considered a routine insider transaction, and investors are advised to monitor such events alongside other company data.
UFP Technologies, Inc. (NASDAQ:UFPT) Just Released Its First-Quarter Earnings: Here's What Analysts Think
UFP Technologies, Inc. (NASDAQ:UFPT) recently released its first-quarter earnings, with shares rising 3.8% following the report. The company met revenue expectations at US$154m and exceeded profit estimates with a statutory profit of US$2.24 per share. Analysts maintain their prior revenue and EPS forecasts for 2026 and have kept the consensus price target steady at US$325, expecting revenue growth to slow but remain in line with the industry.
Ufp Technologies Insider Sold Shares Worth $634,977, According to a Recent SEC Filing
An insider at UFP Technologies sold shares valued at $634,977, according to a recent SEC filing. UFP Technologies specializes in designing and manufacturing solutions for medical devices, sterile packaging, and other engineered custom products. The company also recently reported its Q1 2026 earnings and is actively seeking acquisitions.
Insider Sell: Daniel Croteau Sells Shares of UFP Technologies In
Daniel Croteau, a Director at UFP Technologies Inc (UFPT), sold 2,864 shares of the company on May 12, 2026, reducing his holding to 855 shares. This sale is part of a trend for Croteau, who has sold 5,737 shares in the past year with no purchases. Shares of UFPT were trading at $221.71, and the stock is considered modestly undervalued with a price-to-GF-Value ratio of 0.83.
UFP Technologies (UFPT) director records open-market sale of 2,864 shares
UFP Technologies director Daniel C. Croteau has reported an open-market sale of 2,864 shares of Common Stock at $221.71 per share. This transaction reduced his direct holdings to 855 shares. The sale was documented in a Form 4 filing, indicating a net-sell activity by the insider.
UFP Technologies, Inc. (NASDAQ:UFPT) Just Released Its First-Quarter Earnings: Here's What Analysts Think
UFP Technologies (NASDAQ:UFPT) recently released its first-quarter earnings, showing revenues in line with predictions and a slightly higher-than-expected statutory profit of US$2.24 per share. Four analysts predict a reasonable 5.1% revenue improvement to US$640.0m in 2026 and a 7.1% increase in EPS to US$9.50, with no significant changes to their previous estimates. While the consensus price target remains at US$325, the company's revenue growth is expected to slow down but still align with the industry average.
[144] UFP TECHNOLOGIES INC SEC Filing
This article reports on UFP Technologies Inc.'s SEC Form 144 filing, detailing a proposed sale of common stock by an individual through UBS Financial Services Inc. The filing indicates the acquisition of 2,864 shares on May 8, 2026, through a stock option exercise from the issuer, with payment made in cash. The article also provides an overview of UFPT's financial data, market rankings, and recent news and SEC filings.
UFP Technologies (UFPT) director exercises options to acquire 2,864 shares
UFP Technologies (UFPT) director Daniel C. Croteau exercised stock options to acquire 2,864 shares of common stock at $22.02 per share. Following this transaction, Croteau directly holds 3,719 shares of UFPT common stock. This event is classified as a derivative exercise rather than an open-market purchase or sale.
5 Revealing Analyst Questions From UFP Technologies’s Q1 Earnings Call
UFP Technologies (UFPT) reported Q1 results in line with revenue expectations and beat on adjusted profitability, driven by strong medical sales, particularly in robotic surgery. The company is actively shifting away from nonmedical markets like automotive, focusing on high-growth medical segments and new product launches. Analysts questioned management on growth drivers, nonmedical business decline, the impact of start-up costs, capacity expansion, and inventory slowdowns, providing insights into the company's strategic direction and future catalysts.
UFP Technologies (UFPT) grows Q1 2026 medical sales and maintains strong margins
UFP Technologies reported strong first-quarter 2026 results, with net sales increasing to $154.2 million, primarily driven by a 5.9% growth in medical sales, especially in robotic surgery and patient surfaces. Net income slightly rose to $17.5 million, or $2.24 diluted EPS, and the company maintained a healthy gross margin of 28.8% due to efficiency gains. Despite significant customer concentration and cash absorbed by higher receivables and inventory, UFPT is in compliance with its debt covenants and anticipates reimbursement for past tariff impacts.
Swedbank AB Trims Position in UFP Technologies, Inc. $UFPT
Swedbank AB reduced its stake in UFP Technologies, Inc. (NASDAQ:UFPT) by 13.5% in the fourth quarter, selling 25,000 shares and retaining 160,005 shares valued at $35.53 million. UFP Technologies reported strong quarterly earnings of $2.48 EPS, surpassing estimates, with revenue up 4.1% year-over-year. Analysts currently rate the stock as a "Hold" with a mean price target of $289, and institutional investors collectively own approximately 87.28% of the company's shares.
UFP Technologies Reports Q1 2026 Results: Full Earnings Call Transcript
UFP Technologies reported a 4.1% revenue increase in Q1 2026, driven by a 5.9% rise in medical sales, despite a 15% decline in non-medical sales due to strategic focusing. Earnings per share growth was impacted by startup costs for four new program launches, labor inefficiencies at AJR, and non-recurring legal expenses from a cyber attack and CEO transition. The company is expanding capacity in the Dominican Republic and planning APAC expansion, while CEO Jeff Bailey is transitioning leadership to Mitch Rock.
UFP Technologies, Inc. (NASDAQ:UFPT) Q1 2026 Earnings Call Transcript
UFP Technologies reported Q1 2026 results, with revenue up 4.1% driven by a 5.9% increase in medical sales. The company is strategically focusing on the MedTech space, particularly robotic surgery and patient surfaces, while phasing out of nonmedical segments like automotive. They are also expanding capacity in the Dominican Republic and APAC, with three new programs gaining significant traction for the latter half of the year.
Earnings Flash (UFPT) UFP Technologies, Inc. Reports Q1 Revenue $154.2M, Vs. FactSet Est of $154.8M
UFP Technologies, Inc. (UFPT) announced its first-quarter revenue of $154.2 million, which fell slightly short of the FactSet estimate of $154.8 million. This financial update provides key performance indicators for investors and analysts following the company.
UFP Technologies outlines second-half ramp as 3 of 4 new programs are asked to double capacity
UFP Technologies expects a significant ramp-up in the second half of the year, driven by increased demand for its new programs. Three out of four new programs have requested a doubling of capacity, indicating strong market adoption and future growth potential for the company. This suggests a positive outlook for UFP Technologies' financial performance in the coming months.
UFP Technologies (NASDAQ:UFPT) Shares Gap Down - Time to Sell?
UFP Technologies (NASDAQ:UFPT) experienced a significant gap down in its stock price, opening at $182.50 after closing at $192.55. Despite this, analysts have upgraded their ratings from "sell" to "hold" with a consensus price target of $289.00, following the company's beat on EPS estimates and near-line revenue for the recent quarter. The stock is currently trading below its 50-day and 200-day moving averages, and institutional investors have recently adjusted their holdings.
UFP Technologies stock hits 52-week low at 182.5 USD
UFP Technologies Inc.'s stock has fallen to a 52-week low of $182.5, marking a 12.27% decline over the past year. Despite this, InvestingPro data suggests the stock is undervalued, boasting a "GREAT" financial health score and a market cap of $1.49 billion. Two analysts have revised earnings downward, yet the company maintains strong fundamentals with a P/E ratio of 22.08, and recently surpassed Q1 2026 EPS expectations.
Earnings Flash (UFPT) UFP Technologies, Inc. Posts Q1 Adjusted EPS $2.48 per Share, Vs. FactSet Est of $2.31
UFP Technologies, Inc. (UFPT) reported its Q1 adjusted EPS at $2.48 per share, surpassing the FactSet estimate of $2.31 per share. This indicates a stronger financial performance than analysts anticipated for the quarter.
UFP Technologies posts Q1 revenue $154.2M, net income $17.5M; adjusted diluted EPS $2.48
UFP Technologies announced its first-quarter 2026 financial results, reporting net sales of $154.2 million, a 4.1% increase from the previous year. The company posted a net income of $17.5 million, with an adjusted diluted EPS of $2.48 and an adjusted EBITDA reaching $31.0 million. Key growth drivers included strong performance in medical sales, particularly robotic surgery and patient handling segments, alongside strategic capacity expansion in the Dominican Republic.
UFP Technologies (UFPT) Q1 2026 earnings edge higher on $154M sales
UFP Technologies announced Q1 2026 results with net sales of $154.2 million, a 4.1% increase year-over-year, and net income up 1.8% to $17.5 million. The growth was primarily driven by a 5.9% increase in medical market sales, although non-medical sales declined. The company is focusing on high-growth MedTech opportunities and plans to expand capacity with two new facilities in the Dominican Republic.
Press Release: UFP Technologies Announces Strong Q1 Results
NULL
UFP Technologies Announces Strong Q1 Results
UFP Technologies reported strong Q1 2026 results with net income of $17.5 million, a 1.8% increase, and net sales of $154.2 million, up 4.1% year-over-year. The growth was primarily driven by a 5.9% increase in medical sales, despite a 15% decline in non-medical sales, as the company focuses on high-growth MedTech opportunities. The company also announced plans to expand capacity with two new facilities in the Dominican Republic to support strong forecasted demand in robotic surgery and patient handling segments.
UFP: Q1 Earnings Snapshot
UFP Technologies Inc. (UFPT) reported strong first-quarter earnings, with net income of $17.5 million, or $2.24 per share. Adjusted earnings reached $2.48 per share, and the company posted revenues of $154.2 million for the period. These results were provided by Automated Insights using data from Zacks Investment Research.
Earnings Flash (UFPT) UFP Technologies, Inc. Reports Q1 Revenue $154.2M, vs. FactSet Est of $154.8M
UFP Technologies, Inc. (UFPT) reported its Q1 revenue at $154.2 million, falling slightly short of the FactSet estimate of $154.8 million. The report, published on May 4, 2026, also noted related earnings and revenue increases for the first quarter. This news highlights the company's financial performance compared to analyst expectations.
UFP Technologies faces earnings test amid margin pressure
UFP Technologies Inc. is preparing to report first-quarter results, facing heightened investor focus on profitability trends despite continued revenue growth. Analysts expect a decline in EPS year-over-year due to margin pressure, which will be a key area of discussion for management. The company, a specialist in medical device components, is also undergoing a leadership transition, adding another layer of interest for investors who will be looking for seamless continuity and strategic clarity.
UFP Technologies (UFPT) Reports Q1: Everything You Need To Know Ahead Of Earnings
UFP Technologies (UFPT) is poised to report Q1 earnings this Monday after market close. The market anticipates a 4.5% year-on-year revenue growth, a slowdown from the previous year's 41.1% increase. Despite past revenue misses, analysts have largely reconfirmed their estimates, and the life sciences tools & services segment has shown positive investor sentiment.
Medical-device maker UFP Technologies lines up May 5 investor call
UFP Technologies (NASDAQ: UFPT) announced it will release its first-quarter 2026 financial results on Monday, May 4, 2026, after market close. The company will host a conference call the following day, May 5, 2026, at 8:30 AM Eastern Time to discuss these results. Investors can access dial-in numbers, a live webcast, and a replay on the company's Investor Relations website.
UFP Technologies to Report First Quarter 2026 Financial Results on May 4, 2026
UFP Technologies announced it will release its first-quarter 2026 financial results on May 4, 2026. The company will also host a conference call and webcast to discuss these results.
[ARS] UFP TECHNOLOGIES INC SEC Filing
This article reports on UFP Technologies Inc.'s (UFPT) recent SEC filing of Form ARS. The filing, dated April 29, 2026, at 5:32 PM, is available as a PDF document on SEC EDGAR. The article also provides a company overview, recent news, and other SEC filings for UFPT.
UFP Technologies to Report First Quarter 2026 Financial Results on May 4, 2026
UFP Technologies, Inc. (Nasdaq: UFPT) announced it will release its first-quarter 2026 financial results on Monday, May 4th, after the stock market closes. The company will host a conference call the following day, May 5th, at 8:30 AM Eastern Time to discuss these results. A webcast of the call will be available on the company's Investor Relations website.
Executive shift at UFP Technologies (UFPT) as Rock to become CEO in 2026
UFP Technologies (UFPT) announced a leadership transition where current CEO R. Jeffrey Bailly will retire and become Executive Chairman on June 4, 2026, while President Mitchell C. Rock will assume the role of Chief Executive Officer. The company filed a definitive proxy statement for its virtual annual meeting on June 4, 2026, outlining the election of directors, an advisory vote on executive compensation, and the ratification of Grant Thornton LLP as the independent auditor. The filing also detailed executive compensation policies, emphasizing performance-based incentives tied to Adjusted Operating Income, and highlighted the board's independence and corporate governance practices.
UFP Technologies (UFPT) to Release Earnings on Tuesday
UFP Technologies (UFPT) is scheduled to release its Q1 2026 earnings before market open on Tuesday, May 5th, with analysts forecasting $2.18 EPS and $154.601 million in revenue. The company previously beat estimates in Q4 2025, reporting $2.44 EPS. UFPT currently holds a "Hold" rating from analysts with a consensus target price of $289.00.
UFPT 260515 310.00P (UFPT260515P310000) Stock Options Chain | Quotes & News
This document appears to be a stub or an empty page intended to display information about UFPT 260515 310.00P (UFPT260515P310000) stock options, including its options chain, quotes, and news. However, it currently contains no content.
UFPT 260515 185.00C (UFPT260515C185000) Stock Options Chain | Quotes & News
This document appears to be a placeholder or an empty content piece regarding the stock options chain for UFPT 260515 185.00C (UFPT260515C185000). It likely intends to provide quotes and news related to this specific options contract, but currently contains no substantive information.
Montrusco Bolton Investments Inc. Has $4.51 Million Stock Position in UFP Technologies, Inc. $UFPT
Montrusco Bolton Investments Inc. significantly reduced its stake in UFP Technologies Inc. by 36.8% in Q4, now holding 20,329 shares valued at $4.51 million. Despite this, other institutions like Millennium Management and Jane Street increased their positions, leading to institutional investors owning 87.28% of UFPT. UFP Technologies reported strong Q4 earnings, beating estimates with $2.44 EPS and a 3.4% year-over-year revenue increase.
Congress Asset Management (NASDAQ: UFPT) discloses 5.4% stake in UFP Technologies
Congress Asset Management has filed a Schedule 13G, disclosing a 5.4% beneficial ownership stake in UFP Technologies Inc. (UFPT) as of March 31, 2026. This filing indicates a passive investment where the firm holds 416,762 shares with sole voting and dispositive power, without intent to influence company control. Such filings are standard for investors acquiring significant but non-controlling positions.
Implied Volatility Surging for UFP Technologies Stock Options
This article from Zacks Equity Research discusses the surge in implied volatility for UFP Technologies (UFPT) stock options, reaching 115.1%, indicating increased protection costs for options traders. The article highlights how options are priced based on the stock's expected price movement and that such a high implied volatility suggests that UFPT's stock could experience significant price swings in the near future.
Boston Trust Walden Corp Sells 19,169 Shares of UFP Technologies, Inc. $UFPT
Boston Trust Walden Corp reduced its stake in UFP Technologies (NASDAQ:UFPT) by 7.6% in the fourth quarter, selling 19,169 shares and now owning 232,676 shares valued at $51.66 million. The company represents 3.02% ownership and analysts maintain a consensus "Hold" rating with a $289 target price. UFP Technologies recently exceeded EPS estimates while revenue was largely in line, with the stock trading near $199 and holding a market cap of approximately $1.53 billion.
UFP Technologies' (NASDAQ:UFPT) Earnings Growth Rate Lags the 39% CAGR Delivered to Shareholders
This article analyzes UFP Technologies' stock performance and earnings growth. It highlights that while shareholders have seen a 39% compound annual growth rate (CAGR) over the last five years, the company's earnings per share (EPS) growth has been lower at 17% CAGR. The article suggests that the market might be anticipating future accelerated earnings growth or that the stock's valuation includes a significant goodwill component.
Molded Fiber Pulp Packaging Market Set for Rapid Growth and Trend
The Molded Fiber Pulp Packaging Market is projected to grow from USD 10.74 billion in 2026 to USD 15.93 billion by 2033, demonstrating a compound annual growth rate of 5.8%. A new report by Coherent Market Insights provides a comprehensive analysis of the market's competitive landscape, growth drivers, restraints, trends, and segmentation by pulp type, product type, and end-use across various regions. This study aims to offer businesses and investors precise economic insights and strategic recommendations.
Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know
Shares of Natera (NTRA), UFP Technologies (UFPT), Mettler-Toledo (MTD), and Viatris (VTRS) jumped following the reopening of the Strait of Hormuz, which signaled a decrease in global logistics and energy costs. Lower oil prices are expected to reduce operating and shipping costs for healthcare providers and medical device manufacturers, improving their outlook. This "risk-on" sentiment is also driving capital back into high-growth biotech and pharmaceutical companies as macroeconomic uncertainties recede.
Consumer Electronics Packaging Market is projected to Hit US$
The Consumer Electronics Packaging Market is projected to grow from US$ 31.20 billion in 2025 to US$ 97.18 billion by 2033, driven by sustainability mandates, e-commerce expansion, and increased demand for AI-enabled devices. The market focuses on protective and aesthetic packaging solutions for electronic devices, with a growing emphasis on recyclable and eco-friendly materials. Key players include Pregis LLC, UFP Technologies Inc., and Dordan Manufacturing Company, with significant recent M&A activities shaping the industry.
Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know
Shares of Natera, UFP Technologies, Mettler-Toledo, and Viatris surged following the reopening of the Strait of Hormuz, which is expected to reduce global logistics and energy costs. This development is particularly beneficial for healthcare and medical device sectors, offering margin relief and encouraging "risk-on" investment in biotech and pharmaceutical companies. Lower oil prices and increased economic stability are expected to support long-term R&D and pharmaceutical demand.
Massachusetts Financial Services Co. MA Has $27.05 Million Stock Position in UFP Technologies, Inc. $UFPT
Massachusetts Financial Services Co. MA reduced its stake in UFP Technologies, Inc. (NASDAQ:UFPT) by 28.3% during the fourth quarter, now holding 121,844 shares valued at $27.05 million, representing about 1.58% of the company. Despite this reduction, UFP Technologies recently beat EPS estimates and has strong institutional ownership. Analysts currently rate the stock as "Hold" with an average price target of $289.00, while the stock trades near $196.22.
Is UFP Technologies Inc (UFPT) a Bargain After 3.6% Drop? GF Val
UFP Technologies Inc (UFPT) recently experienced a 3.6% drop, bringing its stock price to $196.03. GuruFocus's GF Value™ indicates the stock is "Modestly Undervalued" at 26.6% below its intrinsic value of $266.89, suggesting a potential buying opportunity. Despite no recent insider transactions, the company holds a strong GF Score™ of 90/100, supported by high profitability and a favorable valuation.
